Israel Corporation reported $426M in Cash and Equivalent for its fiscal quarter ending in September of 2025.





Cash And Equivalent Change Date
Avient USD 427.6M 82.9M Mar/2026
Chemours USD 563M 107M Mar/2026
Corteva USD 1.96B 2.56B Mar/2026
ICL Group USD 291M 65M Dec/2025
Israel Corporation USD 426M 263M Sep/2025
PhosAgro RUB 13.36B 93.57B Dec/2022
UPL INR 41.52B 53.85B Sep/2025